AlphaYouJI
Congress trade
Sen. James Inhofe (R-OK) bought $15K-$50K of Editas Medicine, Inc. (EDIT) stock
James Inhofe, U.S. Senator (R-OK), disclosed a purchase of Editas Medicine, Inc. (EDIT) stock worth $15K-$50K in a STOCK Act filing on Nov 8, 2017.
The trade happened on Oct 19, 2017, 20 days before it was made public.
EDIT has moved -89.1% since the trade date, from $23.95 to $2.62 (Oct 2, 2026 close).
- Traded
- Oct 19, 2017
- Disclosed
- Nov 8, 2017
- Filing delay
- 20 days
- Price since
- -89.1%
- Source
- STOCK Act disclosure
Other trades in this disclosure (10)
More EDIT insider and Congress trades
From a public STOCK Act disclosure, linked above. Not investment advice, and not a recommendation to buy or sell.